BMS And Simcere To Co-develop Orencia In China For RA
This article was originally published in PharmAsia News
Executive Summary
Bristol-Myers Squibb and Simcere Pharmaceutical Group announced a co-development collaboration for rheumatoid arthritis treatment Orencia (abatacept.